Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$0.42 - $0.72 $338,678 - $580,591
-806,377 Reduced 35.36%
1,474,026 $928,000
Q3 2022

Nov 14, 2022

SELL
$1.9 - $8.63 $2.9 Million - $13.2 Million
-1,525,000 Reduced 40.07%
2,280,403 $5.61 Million
Q4 2021

Feb 14, 2022

SELL
$14.7 - $28.67 $22.2 Million - $43.4 Million
-1,512,074 Reduced 28.44%
3,805,403 $58.1 Million
Q3 2021

Nov 15, 2021

BUY
$24.31 - $33.6 $16.3 Million - $22.5 Million
670,084 Added 14.42%
5,317,477 $151 Million
Q2 2021

Aug 16, 2021

SELL
$26.09 - $40.4 $5.34 Million - $8.27 Million
-204,770 Reduced 4.22%
4,647,393 $157 Million
Q1 2021

May 17, 2021

SELL
$33.06 - $56.93 $13.6 Million - $23.4 Million
-411,146 Reduced 7.81%
4,852,163 $185 Million
Q4 2020

Feb 16, 2021

BUY
$39.09 - $57.4 $198 Million - $291 Million
5,068,306 Added 2599.09%
5,263,309 $220 Million
Q3 2020

Nov 16, 2020

SELL
$28.43 - $44.67 $6.71 Million - $10.5 Million
-236,097 Reduced 54.77%
195,003 $8.45 Million
Q2 2020

Aug 14, 2020

BUY
$11.71 - $30.29 $5.05 Million - $13.1 Million
431,100 New
431,100 $13.1 Million
Q3 2019

Nov 14, 2019

SELL
$18.85 - $27.5 $7.08 Million - $10.3 Million
-375,375 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$17.37 - $26.27 $17.3 Million - $26.2 Million
-998,800 Reduced 72.68%
375,375 $8.82 Million
Q1 2019

May 15, 2019

BUY
$10.65 - $25.75 $9.04 Million - $21.9 Million
848,800 Added 161.56%
1,374,175 $32.2 Million
Q3 2018

Nov 14, 2018

SELL
$7.54 - $18.31 $2.16 Million - $5.25 Million
-286,865 Reduced 35.32%
525,375 $8.79 Million
Q2 2018

Aug 14, 2018

SELL
$4.87 - $8.42 $6.46 Million - $11.2 Million
-1,327,280 Reduced 62.04%
812,240 $5.97 Million
Q1 2018

May 15, 2018

SELL
$4.69 - $10.05 $387,018 - $829,326
-82,520 Reduced 3.71%
2,139,520 $0
Q4 2017

Feb 14, 2018

BUY
$7.86 - $9.99 $863,028 - $1.1 Million
109,800 Added 5.2%
2,222,040 $20.2 Million
Q3 2017

Nov 14, 2017

BUY
$8.89 - $10.4 $18.8 Million - $22 Million
2,112,240
2,112,240 $19.8 Million

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Redmile Group, LLC Portfolio

Follow Redmile Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.